Skip to main content
logo
Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,970
+280 (2.05%)
At close: Aug 24, 2026

Sam-A Pharm. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,54512,94022,08021,37411,9123,392
Depreciation & Amortization
4,9184,8084,2663,8953,1873,699
Loss (Gain) From Sale of Assets
-117.32-----
Loss (Gain) From Sale of Investments
-1,034-898.58-404.35-907.911,335308.52
Loss (Gain) on Equity Investments
946.62863.72932.85915.831,2902,464
Provision & Write-off of Bad Debts
0.68-150.7926.23-40.36-16.74
Other Operating Activities
-2,662-3,7717.04-1,1492,2841,485
Change in Accounts Receivable
-1,144-256.73,510-1,090-3,427-2,638
Change in Inventory
2,929-2,357-1,447-885.95-2,9752,666
Change in Accounts Payable
-833.45-1,652827.33-2,0383,2681,210
Change in Other Net Operating Assets
729.681,198-4,551686.512,730339.61
Operating Cash Flow
14,27910,72325,24720,76019,60412,943
Operating Cash Flow Growth
-21.36%-57.53%21.62%5.90%51.47%37.57%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,056-1,370-6,512-3,820-239.25-275.44
Sale of Property, Plant & Equipment
-29.4--140.214.55
Sale (Purchase) of Intangibles
32.38-358.53109.09263.641,1001,050
Investment in Securities
6,588-1,162-15,160-17,251-24,423-34,375
Other Investing Activities
227.67302.41151.75-010,39013,800
Investing Cash Flow
4,792-2,559-21,411-20,807-13,032-19,796

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--5,0005,000--
Total Debt Issued
2,621-5,0005,000--
Long-Term Debt Repaid
--6,246-3,945-2,670-3,855-1,839
Net Debt Issued (Repaid)
-3,657-6,2461,0552,330-3,855-1,839
Dividends Paid
-5,188-4,883-4,578-2,441-1,526-1,831
Financing Cash Flow
-8,845-11,129-3,522-111.77-5,381-3,670

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
25.5-6.08217.642.45-111.9
Miscellaneous Cash Flow Adjustments
----0-00
Net Cash Flow
10,252-2,970531.73-156.461,191-10,411

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12,2239,35318,73516,94019,36512,667
Free Cash Flow Growth
-14.75%-50.08%10.60%-12.52%52.88%45.13%
Free Cash Flow Margin
16.91%12.02%19.60%17.43%23.70%23.17%
Free Cash Flow Per Share
2002.131532.453069.992775.593172.892075.46
Levered Free Cash Flow
6,7383,53911,7789,63417,65811,749
Unlevered Free Cash Flow
7,0133,81512,1159,77117,69711,827

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
311.13425.21519.8214.562.8529.07
Cash Income Tax Paid
1,8866,5967,4817,1864,228802.31
Change in Working Capital
1,681-3,068-1,660-3,327-403.531,577